Refractory Diffuse Alveolar Hemorrhage and Complement-Mediated Thrombotic Microangiopathy with Lupus Nephritis (KIDNEY WEEK 2026) - Oct 2, 2026 - Abstract #SA-PO0758; Pres time: Oct 24, 2026; 10:00 AM - 12:00 PM; Location: Exhibit Hall A, Convention Center; "The scheduled second dose of cyclophosphamide was givenand two 1-g doses of rituximab were added for refractory DAH...She transitioned to mycophenolate and prednisone...At 3 months, anti-dsDNA decreased and complement remained normal. Discussion This case presents a treatment pathway for severe LN-associated DAH with presumed CM- TMA, including rescue ravulizumab and relapse treatment with PLEX, IVIG, antibiotics, and intensified mycophenolate."
Complement-mediated Rare Disorders • Glomerulonephritis • Hematological Disorders • Immunology • Infectious Disease • Inflammatory Arthritis • Lupus • Lupus Nephritis • Nephrology • Pneumonia • Renal Disease • Respiratory Diseases • CFHR3
|
|
Nada Alamri; Fatima Alduraibi
|